Reduced and Normalized Carbohydrate Antigen 19-9 Concentrations after Neoadjuvant Chemotherapy Have Comparable Prognostic Performance in Patients with Borderline Resectable and Locally Advanced Pancreatic Cancer

Background: The association between optimal carbohydrate antigen (CA) 19-9 concentration after neoadjuvant chemotherapy (NACT) and prognosis has not been confirmed in patients with borderline resectable (BRPC) and locally advanced pancreatic cancer (LAPC). Methods: This retrospective study included...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Woohyung, Park, Yejong, Kwon, Jae Woo, Jun, Eunsung, Song, Ki Byung, Lee, Jae Hoon, Hwang, Dae Wook, Yoo, Changhoon, Kim, Kyu-pyo, Jeong, Jae Ho, Chang, Heung-Moon, Ryoo, Baek-Yeol, Park, Seo Young, Kim, Song Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291310/
https://www.ncbi.nlm.nih.gov/pubmed/32423123
http://dx.doi.org/10.3390/jcm9051477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291310/
https://www.ncbi.nlm.nih.gov/pubmed/32423123
http://dx.doi.org/10.3390/jcm9051477

Ejemplares similares